Ether’s dominance lasted barely a year before a more potent agent arrived.
Chloroform was easier to use, faster acting, and more pleasant to inhale.
It was also, as the profession would spend decades establishing, significantly
more likely to kill the patient without warning.
James Young Simpson, a Glasgow-trained obstetrician then holding the
Chair of Midwifery at Edinburgh, was searching for an alternative to ether
more suitable for childbirth. In November 1847, he and two colleagues
inhaled chloroform in his dining room and were discovered unconscious on
the floor. Satisfied with the result, Simpson introduced it into his
obstetric practice almost immediately.
(Shephard, Journal of the Royal College of Physicians of Edinburgh, 2011)
Chloroform’s social acceptance was accelerated by a single high-profile
event. On 7 April 1853, John Snow administered it to Queen Victoria during
the birth of Prince Leopold. Victoria described the effect as
“soothing, quieting and delightful beyond measure.” The royal endorsement
effectively closed the theological debate — some clergy had argued that
pain in childbirth was divinely ordained — and normalised obstetric
anaesthesia for a generation of patients.
(Caton, Anesthesiology, 2000)
The first death directly attributed to chloroform occurred in January 1848,
less than three months after Simpson’s introduction of the drug. Hannah
Greener, a healthy 15-year-old girl, died during a minor elective procedure
to remove an ingrowing toenail at Winlaton, County Durham. Her collapse
was abrupt and unexplained. The attending surgeon attempted resuscitation
with brandy and cold water, to no effect.
(Knight & Bacon, Anaesthesia, 2002)
Greener’s death opened a prolonged period of medical anxiety. More than
fifty fatalities associated with chloroform appeared in the literature within
the first decade of its use. John Snow, compiling the first fifty known
deaths for his 1858 posthumous treatise On Chloroform and Other
Anaesthetics, found that in 46 of those cases the patient had died
before the surgery had even begun — during induction alone. The quantified
risk was stark: deaths from ether ran at approximately 1 in 25,000;
deaths from chloroform ran substantially higher.
(Duncum, Proceedings of the Royal Society of Medicine, 1974)
The British Medical Association formed a Special Chloroform Committee to
investigate. Its inquiries continued intermittently for over half a century,
with major reports issued in 1893 and 1901. The committee’s work represents
one of the earliest examples of a professional medical body attempting
systematic evidence gathering in response to a drug-safety crisis.
(British Medical Association, Final Report of the Special Chloroform Committee, JSTOR)